Home   Sheerness   News   Article

Teen to face trial for supplying ecstasy following death of Sheppey Oasis Academy pupil Emre Huseyin

A 17-year-old is to face trial at crown court following the death of a teenager.

The youth, who cannot be named because of his age, is charged with supplying the drug MDMA, sometimes known as ecstasy, on Saturday, February 1, in Sheerness.

Emre Huseyin
Emre Huseyin

Later that evening Oasis Academy pupil Emre Huseyin collapsed and died at his home in Berridge Road, Sheerness. He was just five days short of his 16th birthday.

The youth from Sidcup appeared at Medway Magistrates' Court on Tuesday and was committed to Maidstone Crown Court for trial on Tuesday, March 10.

He is also accused of threatening a person with a knife following an unrelated incident which also took place in Sheerness on the dame day.

He has been released on conditional bail. He must not visit the Isle of Sheppey or contact any witnesses.

He was told to co-operate with the youth offending team and must wear a tag. He is on a curfew and must be home between 7pm and 6am.

Friends gather at the candlelit vigil for Emre Huseyin in New Road playing fields, Sheerness, on Thursday. It would have been his 16th birthday
Friends gather at the candlelit vigil for Emre Huseyin in New Road playing fields, Sheerness, on Thursday. It would have been his 16th birthday

A second boy, also 17 and from Orpington, was also arrested in connection with supplying drugs and was released on police bail until Wednesday, February 26.

The drug methyl​enedioxy​methamphetamine (MDMA) is commonly known as ecstasy, E, XTC or molly.

Classmates staged an evening vigil in memory of Emre last Thursday on what would have been his16th birthday.

The school held a service for him on Tuesday evening.

To read more of our in depth coverage of all of the major trials coming out of crown and magistrates' courts across the county, click here.

Read more: All the latest news from Sheppey


More by this author


Close This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.Learn More